Institutional investors purchased a net $1.1 million shares of GSK during the quarter ended December 2016 and now own 8.88% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 2.3 Million shares of GlaxoSmithKline
TWO SIGMA ADVISERS LP Bought 2.3 Million shares of GlaxoSmithKline
RENAISSANCE TECHNOLOGIES LLC Bought 2.2 Million shares of GlaxoSmithKline